These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11922470)

  • 21. Ovomucin nanoparticles: promising carriers for mucosal delivery of drugs and bioactive compounds.
    Akbari A; Wu J
    Drug Deliv Transl Res; 2017 Aug; 7(4):598-607. PubMed ID: 28717995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Synthesis and study of immobilized insulin].
    Valuev IL; Valuev LI; Sytov GA; Platé NA
    Biokhimiia; 1996 Sep; 61(9):1584-8. PubMed ID: 8998283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Production methodologies of polymeric and hydrogel particles for drug delivery applications.
    Lima AC; Sher P; Mano JF
    Expert Opin Drug Deliv; 2012 Feb; 9(2):231-48. PubMed ID: 22250602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Review of Injectable Polymeric Hydrogel Systems for Application in Bone Tissue Engineering.
    Kondiah PJ; Choonara YE; Kondiah PP; Marimuthu T; Kumar P; du Toit LC; Pillay V
    Molecules; 2016 Nov; 21(11):. PubMed ID: 27879635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Action of duck's egg white ovomucoid on tryptic hydrolysis of casein in vitro.
    VIJAYARAGHAVAN PK; NARASINGA RAO BS
    Nature; 1953 Dec; 172(4390):1152-3. PubMed ID: 13111276
    [No Abstract]   [Full Text] [Related]  

  • 26. Development of PEGDMA: MAA based hydrogel microparticles for oral insulin delivery.
    Kumar A; Lahiri SS; Singh H
    Int J Pharm; 2006 Oct; 323(1-2):117-24. PubMed ID: 16828246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Properties of duck ovomucoid purified by affinity chromatography on trypsin-Sepharose].
    Shul'gin MN; Valueva TA; Kestere AIa; Mosolov VV
    Biokhimiia; 1981 Mar; 46(3):473-80. PubMed ID: 6786376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral bioavailability of insulin contained in polysaccharide nanoparticles.
    Sarmento B; Ribeiro A; Veiga F; Ferreira D; Neufeld R
    Biomacromolecules; 2007 Oct; 8(10):3054-60. PubMed ID: 17877397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Photopolymerizable hydrogels for tissue engineering applications.
    Nguyen KT; West JL
    Biomaterials; 2002 Nov; 23(22):4307-14. PubMed ID: 12219820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymeric nanoparticle drug delivery technologies for oral delivery applications.
    Pridgen EM; Alexis F; Farokhzad OC
    Expert Opin Drug Deliv; 2015; 12(9):1459-73. PubMed ID: 25813361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeted Gastrointestinal Delivery of Nutraceuticals with Polysaccharide-Based Coatings.
    Sampathkumar K; Loo SCJ
    Macromol Biosci; 2018 Apr; 18(4):e1700363. PubMed ID: 29479799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hydrogel Composites Containing Sacrificial Collapsed Hollow Particles as Dual Action pH-Responsive Biomaterials.
    Pafiti K; Cui Z; Adlam D; Hoyland J; Freemont AJ; Saunders BR
    Biomacromolecules; 2016 Jul; 17(7):2448-58. PubMed ID: 27267971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [For treatment of diseases involving the inner ear: the frontier of basic research].
    Nakagawa T
    Nihon Jibiinkoka Gakkai Kaiho; 2008 Oct; 111(10):655-63. PubMed ID: 19119529
    [No Abstract]   [Full Text] [Related]  

  • 34. The influence of polymer architecture on the protective effect of novel comb shaped amphiphilic poly(allylamine) against in vitro enzymatic degradation of insulin--towards oral insulin delivery.
    Thompson CJ; Tetley L; Cheng WP
    Int J Pharm; 2010 Jan; 383(1-2):216-27. PubMed ID: 19766178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A hydrogel based on a polyaspartamide: characterization and evaluation of in-vivo biocompatibility and drug release in the rat.
    Giammona G; Pitarresi G; Tomarchio V; Cacciaguerra S; Govoni P
    J Pharm Pharmacol; 1997 Nov; 49(11):1051-6. PubMed ID: 9401936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigations on proteins and polymers. X. Composition and fractionation of ovomucoid.
    BIER M; TERMINIELLO L; DUKE JA; GIBBS RJ; NORD FF
    Arch Biochem Biophys; 1953 Dec; 47(2):465-73. PubMed ID: 13114916
    [No Abstract]   [Full Text] [Related]  

  • 37. Mucoadhesive polymers for oral transmucosal drug delivery: a review.
    Bagan J; Paderni C; Termine N; Campisi G; Lo Russo L; Compilato D; Di Fede O
    Curr Pharm Des; 2012; 18(34):5497-514. PubMed ID: 22632395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of TRI-726 as a drug delivery matrix.
    Mondal P; Alur HH; Johnston TP
    Drug Dev Ind Pharm; 2011 Aug; 37(8):995-1001. PubMed ID: 21417600
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protection of salmon calcitonin breakdown with serine proteases by various ovomucoid species for oral drug delivery.
    Shah RB; Khan MA
    J Pharm Sci; 2004 Feb; 93(2):392-406. PubMed ID: 14705196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polymeric Biomaterial and Lipid Based Nanoparticles for Oral Drug Delivery.
    Dilnawaz F
    Curr Med Chem; 2017; 24(22):2423-2438. PubMed ID: 27804879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.